(Q33397396)

26 July 2017

0 references

Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system (English)

1 reference

26 July 2017

1 reference

E C Vamvakas

1

1 reference

26 July 2017

publication date

30 September 2011

1 reference

26 July 2017

1 reference

26 July 2017

volume

102

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

302-316

1 reference

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Protecting the blood supply from emerging pathogens: the role of pathogen inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Pathogen inactivation: a new paradigm for blood safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Pathogen inactivation: making decisions about new technologies. Report of a consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Dose of prophylactic platelet transfusions and prevention of hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic plat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Regulation of mRNA translation and stability by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Existence of a microRNA pathway in anucleate platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Biosynthesis of major platelet proteins in human blood platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Change in protein phenotype without a nucleus: translational control in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Transfection of human platelets with short interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

MicroRNAs in platelet production and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Equipoise and the ethics of clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

Equipoise and the Dilemma of Randomized Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01555.X

10.1111/J.1423-0410.2011.01555.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference